vimarsana.com

Page 10 - வெற்றி சதுரம் தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Victory Square Provides Corporate Update on Record Year

Victory Square Provides Corporate Update on Record Year Net income for the nine-month period ending September 30th, 2020 was $13,617,124 and earnings per share of $0.18 Completed an oversubscribed $6.1 Million private placement Significant growth by Victory Square companies in key sectors: Digital Health, eSports, Gaming, Crypto, ARVR, Cybersecurity, Cloud Computing and Plant-based Sciences Victory Square spin-off, FansUnite Entertainment Inc., reached $150 Million CAD … Net income for the nine-month period ending September 30th, 2020 was $13,617,124 and earnings per share of $0.18 Completed an oversubscribed $6.1 Million private placement Significant growth by Victory Square companies in key sectors: Digital Health, eSports, Gaming, Crypto, AR/VR, Cybersecurity, Cloud Computing and Plant-based Sciences

Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union  - Press Release

Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union  - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.

Victory Square Technologies Receives Approval for Sale & Distribution of VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test for Entire European Union

Share: Victory Square Technologies received the CE designation from the European Union (EU) competent authority of Belgium for VS SARS CoV-2 Antigen Rapid 15 Minute test on December 18th, 2020. The Company s VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test has a 92 % Sensitivity, 99.2% Specificity, and can confirm whether one is currently infected with the virus causing Covid-19 and is unaware of the infection This Covid-19 Rapid Antigen Test approval further enables Victory Square Technologies to distribute all three testing products (Elisa, Antibody & Antigen) throughout the 27 EU & EEA countries with a combined population of 446,824,564 This EU approval for the Company s VS SARS CoV-2 Antigen 15 Minute Nasal Rapid Test is in addition to the Company s Safetest Covid-19 Antibody 15 Minute Rapid Test previously approved and issued by the EU/EEA on October 16, 2020

Victory Square Technologies Announces Completion of Asset Purchase from Techstars 2019 Alumni Company GameOn App Inc and Appointment of Matt Bailey as Chief Executive Officer of V2 Games Inc

Price ) to such directors, employees and consultants of GameOn as GameOn may direct. V2 Games has also agreed to use commercially reasonable efforts to complete a financing with gross proceeds of at least $1,500,000 at a price of $0.25 per share (the V2 Games Financing ) prior to completion of the Going Public Transaction. The board of directors of V2 Games (the Board ) will be reconstituted to consist of five members, three of whom will be nominees of V2 Games and two of whom will be nominees of GameOn. The details of the reconstitution of the Board will be announced in due course.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.